Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT02864485	TitleTrasplante hepático de donante vivo para metástasis hepáticas de cáncer colorrectal irresecable	Fase No aplicable	Date Added 2016-08-12	Ubicación Canadá	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03494946	TitleLiver Transplantation Compared to Chemotherapy in Patients With ColoRectal Cancer	Fase No aplicable	Date Added 2018-04-11	Ubicación Noruega	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Quimioterapia	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03796884	TitleLinaclotide in Treating Patients With Stages 0-3 Colorectal Cancer	Fase Fase 2	Date Added 2019-01-08	Ubicación Pennsylvania, United States Washington, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Linaclotide	Etiquetas MSS/ MMRp
NCT ID NCT06099821	TitleKN046 más regorafenib o apatinib en cánceres del aparato digestivo MSI-H resistentes al bloqueo de PD-1/PD-L1	Fase Fase 2	Date Added 2023-10-25	Ubicación China	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas apatinib, KN046, Regorafenib	Etiquetas MSI-H/ MMRd
NCT ID NCT03667170	TitleKN035 for dMMR/MSI-H Advanced Solid Tumors	Fase Fase 2	Date Added 2018-09-12	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd
NCT ID NCT06634875	TitleIsunakinra Alone and in Combination with Pembrolizumab in Patients with Colorectal Cancer (MSS)	Fase Fase 2	Date Added 2024-10-10	Ubicación California, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSS/ MMRp
NCT ID NCT03867799	TitleiSCORE: Immunotherapy Sequencing in COlon and REctal Cancer	Fase Fase 2	Date Added 2019-03-08	Ubicación Reino Unido	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Nivolumab	Etiquetas MSS/ MMRp
NCT ID NCT06047015	TitleIrreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal Cancer	Fase Fase 1	Date Added 2023-09-21	Ubicación	Prior IO Allowed Sí	CRC-directed Sí	Status Aún no se ha contratado	Drogas	Etiquetas MSS/ MMRp
NCT ID LUMINESCENCE	TitleIpilimumab, Maraviroc and Nivolumab (LUMINESCENCE)	Fase Fase 1	Date Added 2019-01-25	Ubicación	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Ipilimumab, maraviroc, Nivolumab, Celsentri, Opdivo, Selzentry, Yervoy	Etiquetas MSS/ MMRp
NCT ID NCT02668770	TitleIpilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies	Fase Fase 1	Date Added 2016-01-29	Ubicación Texas, United States	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas Ipilimumab, MGN1703	Etiquetas MSS/ MMRp

Showing 141 to 150 of 299 entries